NAVARA HEALTH
Functional · Hormonal · Aesthetic · Integrative
Nutraceutical & Dispensary Consent

Supplement Recommendation
& Purchase Consent

Including Fullscript Dispensary Disclosure
Practice
Navara Health, PLLC
5301 Alpha Road, Suite 34, Room 21
Dallas, Texas 75240
Contact
469-653-3124
contact@navarahealthtx.com
Treating Provider
Jessica Boggs, MSN, APRN, FNP-C, ENP-C
Medical Director
Simal Patel, MD

Purpose of This Consent

This consent describes the framework under which Navara Health, PLLC recommends nutraceutical supplements as part of my care, the regulatory status of these products, known and potential interaction risks, and the financial disclosure regarding the Navara Health Fullscript dispensary. This document applies to all supplement recommendations made during my care unless I revoke it in writing.

Two-Part Documentation. This master consent covers the general framework for supplement recommendations. When a specific supplement protocol is recommended for me, I will also receive (and where requested, sign) a per-recommendation acknowledgment documenting the specific products, doses, and clinical rationale (Section 11). Together, the two documents form the complete consent record.

Regulatory & FDA Disclosure (DSHEA)

Under the Federal Food, Drug, and Cosmetic Act and the Dietary Supplement Health and Education Act of 1994 (DSHEA), vitamins, minerals, trace elements, amino acids, herbs, botanicals, nutraceuticals, and homeopathic remedies are not classified as drugs and are not FDA-approved to diagnose, treat, cure, or prevent any disease.

I understand and acknowledge:

Purpose of Supplement Recommendations

Supplement recommendations at Navara Health are personalized and made in the context of my overall care plan, which may include:

I understand that supplements are intended to support normal physiological function and are not a replacement for primary care, specialty medical care, prescription medications, or emergency treatment.

Interactions, Side Effects & Disclosure Requirements

Supplements may interact with prescription medications, other supplements, and disease states in clinically meaningful ways. Common high-risk interactions I should be aware of include, but are not limited to:

Anticoagulants & Antiplatelets

Increased bleeding risk: fish oil/omega-3, garlic, ginkgo biloba, ginger, turmeric/curcumin (high dose), vitamin E (high dose), nattokinase, and serrapeptase may increase bleeding when combined with warfarin, apixaban, rivaroxaban, dabigatran, aspirin, or clopidogrel.

Antidepressants & Psychiatric Medications

Serotonin syndrome risk: St. John's Wort, SAMe, 5-HTP, L-tryptophan, and rhodiola may interact with SSRIs, SNRIs, MAOIs, and other serotonergic medications. St. John's Wort also affects metabolism of many medications via CYP3A4 induction.

Thyroid Medications

Calcium, iron, magnesium, and biotin may interfere with absorption of levothyroxine. Take thyroid medication at least 4 hours apart from these. Biotin can also distort certain lab tests including thyroid panels — discontinue 72 hours before lab draws.

Blood Pressure & Cardiac Medications

Licorice root may cause potassium loss and hypertension. Hawthorn, CoQ10, and L-arginine may augment blood pressure medication effects. Grapefruit (in any form) interacts with statins, calcium channel blockers, and many other drugs.

Diabetes & GLP-1 Medications

Berberine, chromium, alpha-lipoic acid, gymnema, and bitter melon may have additive hypoglycemic effects with metformin, sulfonylureas, insulin, or GLP-1 medications. Patients on GLP-1 therapy should disclose all supplements due to delayed gastric emptying which may alter supplement absorption and timing.

Hormone Therapies

DIM, calcium-D-glucarate, and certain phytoestrogens may modulate estrogen metabolism. Maca, ashwagandha, and adaptogens may affect cortisol and thyroid balance. Phytoestrogens may interfere with hormone-sensitive conditions. Discuss any supplement changes if you are on BHRT, TRT, or other hormone therapy.

Sedatives & Sleep Aids

Melatonin, valerian, kava, magnolia, GABA, and certain herbs may potentiate sedative medications and alcohol. Kava has additional liver toxicity warnings.

Lab Interference

Biotin (high dose) interferes with many immunoassay-based lab tests including thyroid, troponin, hCG, and hormone panels. Discontinue biotin at least 72 hours before labs. High-dose vitamin C may affect glucose meter readings.

This list is not exhaustive. Potential interactions may not be fully known or documented for all supplement-medication combinations. I agree to:

Failure to disclose this information may increase the risk of adverse effects.

Pre-Procedure & Pre-Surgery Supplement Hold

Critical Pre-Procedure Safety

Supplements That May Need To Be Held Before Surgery, Anesthesia, or Invasive Procedures

Many supplements affect bleeding, platelet function, anesthesia metabolism, or cardiovascular response. Before any surgery, dental procedure with sedation, endoscopy, colonoscopy, aesthetic injection procedure, microneedling, or other invasive procedure, I will inform my surgeon, dentist, or anesthesiologist of all supplements I am taking. Common supplements that may need to be held 7–14 days before procedures include:

I will not stop supplements pre-procedure without provider guidance if I am taking them for a specific clinical reason. I will follow my surgeon's or anesthesiologist's specific hold instructions, which may differ based on the type of procedure.

Fullscript Dispensary & Practitioner Disclosure

Transparency Disclosure · FTC & Texas Board Compliance

Important Financial Disclosure Regarding Fullscript

Navara Health, PLLC operates a Fullscript professional dispensary, which allows me to order practitioner-grade supplements through the practice. I understand and acknowledge the following:

Product Quality Considerations

When supplements are recommended, Navara Health selects products based on:

I understand that:

No Guarantee of Results

I acknowledge that:

Financial Disclosure

Communication & HIPAA Authorization

I authorize Navara Health to communicate with me regarding supplement recommendations, refills, dosing changes, lab results, and follow-up through:

I understand that email and SMS are not fully secure channels. I may revoke authorization for any specific channel in writing to contact@navarahealthtx.com.

Limitation of Liability

I voluntarily assume all risks associated with the use of supplements, including those recommended by Navara Health, those purchased through Fullscript, and those obtained from other sources after recommendation. To the fullest extent permitted by law, I agree to release, indemnify, and hold harmless:

from liability related to:

This release does not apply to cases of gross negligence or willful misconduct, and does not waive any right that cannot lawfully be waived under the laws of the State of Texas.

Per-Recommendation Acknowledgment

Documentation of Specific Recommendations (For Use At Each Visit)

Each time a specific supplement protocol is recommended for me, the following table will be completed by my provider and reviewed with me. My initials in the right-hand column confirm I understand the recommendation, the clinical reason, and that I have been given the opportunity to ask questions. This block may be left blank at initial signing of the master consent and completed at each visit thereafter.

Supplement / Product Dose & Schedule Clinical Reason My Initials
    
    
    
    
    
    

Visit Date: ____________________    Provider Initials: ____________________

Dispute Resolution & Governing Law

Any dispute, controversy, or claim arising out of or relating to this Consent or any supplement recommendation shall first be addressed by good-faith negotiation. If not resolved within thirty (30) days, the parties agree to submit the dispute to binding arbitration in Dallas County, Texas, under the rules of a recognized arbitration body. The parties waive the right to a jury trial.

This Consent shall be governed by the laws of the State of Texas. If any provision is found unenforceable, the remaining provisions shall remain in full force and effect.

Patient Initials — Required for Each Critical Clause

Each of the following requires my separate written initials.
I understand that supplements are not FDA-approved drugs and that statements about supplements have not been evaluated by the FDA (DSHEA disclosure).
Initials
I understand the specific interaction categories in Section 3, including risks with anticoagulants, antidepressants, thyroid medications, and GLP-1 therapy.
Initials
I understand the pre-procedure supplement hold guidance in Section 4 and agree to disclose all supplements to any surgeon, dentist, or anesthesiologist.
Initials
Fullscript dispensary disclosure: I understand that Navara Health receives a percentage of purchases through the Navara Fullscript dispensary, that I am under no obligation to purchase through Fullscript or to purchase recommended supplements at all, and that my choice of source does not affect my care.
Initials
I agree to disclose all medications, supplements, hormones, peptides, and therapies I am using at every visit, and to report adverse reactions promptly.
Initials
I agree to binding arbitration as described in Section 12 and understand that I am waiving the right to a jury trial.
Initials

Acknowledgment & Electronic Consent

By signing below (or by typing my full legal name as an electronic signature), I confirm and agree:

Patient Printed Name
Date of Birth
Patient Signature (or Typed Electronic Signature)
Date
Provider Signature — Jessica Boggs, APRN, FNP-C, ENP-C
Date